Inmed announces changes to its board of directors

Vancouver, british columbia, aug. 09, 2022 (globe newswire) -- inmed pharmaceuticals inc. (“inmed” or the “company”) (nasdaq: inm), a leader in the research, development, manufacturing and commercialization of rare cannabinoids, is pleased to announce the appointment of nicole lemerond to its board of directors, effective immediately.

INM Ratings Summary

INM Quant Ranking